StockNews.com started coverage on shares of Veradigm (NASDAQ:MDRX – Get Free Report) in a research note issued to investors on Sunday. The firm set a “hold” rating on the software maker’s stock.
Separately, TD Cowen lowered their price target on shares of Veradigm from $26.00 to $15.00 and set a “buy” rating for the company in a report on Tuesday, May 28th. Four research analysts have rated the stock with a hold rating and two have given a buy rating to the stock. Based on data from MarketBeat, the company presently has an average rating of “Hold” and an average target price of $12.00.
View Our Latest Analysis on Veradigm
Veradigm Price Performance
Institutional Inflows and Outflows
Several institutional investors and hedge funds have recently bought and sold shares of the stock. Campbell & CO Investment Adviser LLC lifted its stake in shares of Veradigm by 5.7% in the fourth quarter. Campbell & CO Investment Adviser LLC now owns 42,113 shares of the software maker’s stock valued at $442,000 after buying an additional 2,263 shares in the last quarter. Innealta Capital LLC bought a new stake in Veradigm during the 2nd quarter worth approximately $38,000. Assetmark Inc. lifted its holdings in shares of Veradigm by 7.3% in the fourth quarter. Assetmark Inc. now owns 66,537 shares of the software maker’s stock valued at $698,000 after purchasing an additional 4,529 shares in the last quarter. TFO Wealth Partners LLC grew its holdings in Veradigm by 105,280.0% during the fourth quarter. TFO Wealth Partners LLC now owns 5,269 shares of the software maker’s stock worth $52,000 after buying an additional 5,264 shares in the last quarter. Finally, Meadow Creek Wealth Advisors LLC purchased a new stake in Veradigm in the 1st quarter valued at $83,000.
Veradigm Company Profile
Veradigm Inc, a healthcare technology company, provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), information connectivity, private cloud hosting, outsourcing, analytics, patient access, and population health management solutions.
Featured Articles
- Five stocks we like better than Veradigm
- Golden Cross Stocks: Pattern, Examples and Charts
- The Average 401k Balance by Age Explained
- 2 Fintech Stocks to Buy Now and 1 to Avoid
- 3 Uranium Stocks To Gain as Microsoft Goes Nuclear to Power AI
- The 3 Best Retail Stocks to Shop for in August
- Biotech Boom Ahead? Key Stocks and ETFs to Watch Now
Receive News & Ratings for Veradigm Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Veradigm and related companies with MarketBeat.com's FREE daily email newsletter.